Position in HIMS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$767,177
+$227,272 QoQ
Shares Held
22,128
-14.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#235
of 506 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $10,332,357 across 6 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
57,590 | $4,591,650 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
10,008 | $1,686,748 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
20,150 | $1,288,592 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
30,000 | $1,086,000 | |
| 5 | ZTS |
Zoetis Inc.
|
12,694 | $912,190 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
This page
|
22,128 | $767,177 |
All Filings in HIMS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $767,177 | 22,128 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $539,905 | 26,007 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $831,848 | 25,619 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,829,843 | 32,261 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,659,406 | 33,288 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,739,726 | 58,874 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,175,800 | 48,627 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $930,725 | 50,528 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,102,676 | 54,615 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $850,293 | 54,964 | Shares | Sole | 2024-05-02 | |
| 2023-06-30 | $381,170 | 40,550 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||